Pro-Euro-DILI Registry: Creation of a multicentre and multidisciplinary European registry of prospective drug-induced liver injury cases
1st February 2016 - ongoing
Status: In Recruitment
Specialism: Liver, Drug-Induced Liver Injury.
- To set-up an international European registry of patients with idiosyncratic DILI, (iDILI) enrolled prospectively with the collation of in-depth phenotyping: including details of drug dose, duration, concomitant medications, host demography, comorbidity including insulin sensitivity as well as the course of the event.
- To enrol a similarly well-characterised control group of people who are exposed to medications matched for those implicated in DILI.
- To collect and store biological samples (blood, urine, stool and liver biopsy) from patients with idiosyncratic DILI through the course (at onset and follow-up) of the event.
|Professor Guruprasad Aithal||Biography Professor Guruprasad P. Aithal is the Professor of Hepatology and the Head of the Division for the Nottingham Digestive Diseases Centre and Deputy Director of Nottingham Molecular Pathology Node. Professor Aithal is the GI & Liver Disorder…|
|Dr Jane Grove||I am an Assistant Professor in the Hepatology Group in the NIHR Nottingham Biomedical Research Centre and the MRC-funded Nottingham Molecular Pathology Node (http://www.nmpn.info/). My research includes translational research projects in the following…|